Role of a serum‐based biomarker panel in the early diagnosis of lung cancer for a cohort of high‐risk patients

BACKGROUND This study applied a combined cancer biomarker panel to clinically identify small cell lung cancer (SCLC) and non–small cell lung cancer (NSCLC) in a high‐risk population. METHODS The serum levels of 4 biomarkers (progastrin‐releasing peptide [ProGRP], carcinoembryonic antigen [CEA], squa...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer 2015-09, Vol.121 (S17), p.3113-3121
Hauptverfasser:	Yang, Da-Wei, Zhang, Yong, Hong, Qun-Ying, Hu, Jie, Li, Chun, Pan, Bai-Shen, Wang, Qun, Ding, Fei-Hong, Ou, Jia-Xian, Liu, Fang-Lei, Zhang, Dan, Zhou, Jie-Bai, Song, Yuan-Lin, Bai, Chun-Xue
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antigens, Neoplasm - blood biomarker Biomarkers, Tumor - blood Carcinoembryonic Antigen - blood Carcinoma, Non-Small-Cell Lung - blood Carcinoma, Non-Small-Cell Lung - pathology China delayed diagnosis Early Detection of Cancer Female Humans Keratin-19 - blood Male Middle Aged non–small cell lung cancer Peptide Fragments - blood progastrin‐releasing peptide (ProGRP) Recombinant Proteins - blood Serpins - blood small cell lung cancer Small Cell Lung Carcinoma - blood Small Cell Lung Carcinoma - pathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!